During the past decade, Adobe Clinical Research LLC conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 16 clinical trials were completed, i.e. on average, 94.1% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 12 clinical trials were completed. i.e. 240% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Adobe Clinical Research LLC" #1 sponsor was "Celgene" with 3 trials, followed by "Allergan" with 2 trials sponsored, "Bausch Health Americas, Inc." with 2 trials sponsored, "Hepion Pharmaceuticals, Inc." with 2 trials sponsored and "Ironwood Pharmaceuticals, Inc." with 2 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Adobe Clinical Research LLC" #1 collaborator was "Parexel" with 2 trials as a collaborator, "Allergan Sales, LLC" with 1 trials as a collaborator, "Ironwood Pharmaceuticals, Inc." with 1 trials as a collaborator, "Novo Nordisk A/S" with 1 trials as a collaborator and "RTI Health Solutions" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Adobe Clinical Research LLC" are "Crohn's Disease" (3 trials), "Nonalcoholic Steatohepatitis" (3 trials), "Chronic Idiopathic Constipation" (2 trials), "Eosinophilic Esophagitis (EoE)" (2 trials) and "Gastroparesis" (2 trials). Many other conditions were trialed in "Adobe Clinical Research LLC" in a lesser frequency.

Most popular intervention types in "Adobe Clinical Research LLC" are "Drug" (23 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (14 trials), "RPC1063" (3 trials), "Linaclotide" (2 trials), "Oral Budesonide Suspension (OBS)" (2 trials) and "AXA1125" (1 trials). Other intervention names were less common.

The vast majority of trials in "Adobe Clinical Research LLC" are 24 trials for "All" genders.

Currently, there are NaN active trials in "Adobe Clinical Research LLC". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Adobe Clinical Research LLC, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Adobe Clinical Research LLC, 0 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".